Back
Monopar Therapeutics Inc. MNPR · Insights
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therape... Price73.75
Market Cap495.02 M
Float5.27 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro